Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lianbo Pharmaceutical, often associated with its founder Xiao Lianbo, is a China-based pharmaceutical company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. The company focuses on high-value small molecule chemistry, providing critical components for drugs targeting infectious diseases, cardiovascular health, and central nervous system disorders. Lianbo operates significant manufacturing facilities that adhere to international quality standards, enabling it to serve both domestic and global pharmaceutical markets. Its business model combines proprietary product development with contract manufacturing services for global life science partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiao Lianbo.